Filing metadata

Accession number
0001302443-25-000008
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
Nov 21, 2025
Reporting period
Nov 19, 2025
Description
Insider transaction

Explore SEC Filings Hub